Atherosclerosis Drugs Flashcards

(41 cards)

1
Q

What is the mechanism of Atorvastatin/Lovastatin/Simvastatin?

A

Competitive inhibitors for active site of HMG Co-A reductase (structural analog of HMG CoA intermediate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharmacokinetics of Atorvastatin/Lovastatin/Simvastatin?

A
  • Extensive first pass metabolism by liver (limits systemic bioavailability)
  • High plasma protein binding
  • Variable half life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is the statins metabolized?

A

CYB3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are Lovastatin and Simvastatin metabolized?

A

Administered as inactive lactones that must be transformed in liver. Prodrugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the adverse effects of Statin drugs?

A
  • Usually well tolerated
  • Myopathy (symmetrical,proximal)
  • Rhabdomyolysis (breakdown of muscle fibers)
  • GI/liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When are statins contraindicated?

A
Pregnant
Lactating 
Likely to be pregnant
Active liver disease
Hypersensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical uses of statins?

A

First line therapy in Hypercholesterolemia when at risk for MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the lipoprotein profile or statins?

A

TG - decrease 20-55%
LDL - decrease 20-55%
HDL - increase 5-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the bile acid binding drug?

A

Cholestyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mechanism of Cholestyramine?

A

Highly positively charged that binds bile acids –> depletes bile acid pool and hepatic bile acid synthesis increases –> hepatic cholesterol declines and stimulates production of LDL receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the pharmacokinetics of Cholestyramine?

A
  • Not absorbed! (no systemic S/E)

- Administered as chloride salt/insoluble in water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are adverse effects of Cholestyramine?

A

Constipation/bloating
Interferes with absorption of other drugs
Modest increase in TG/with time returns to baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are C/I of Cholestyramine?

A

Hypercholesterolemia

Increased TG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are clinical uses of Cholestyramine?

A

Hypercholesterolemia
Second line if statin does not lower LDL-C levels
Recommended for patients 11-20 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is lipoprotein profile of Cholestyramine?

A

TG - significant increase when levels increased to begin with
LDL - decrease by 12-25%
HDL - increase by 4-5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of Niacin?

A

Inhibits FFA mobilization in adipose tissue
Decreases synthesis of VLDL, TG in liver
Inhibits uptake of HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the pharmacokinetics of Niacin?

A

Oral administration
3 different formulations
Much greater dose needed for lowering TG than those used as vitamin

18
Q

What are adverse effects of Niacin?

A

Intense cutaneous flush (treat with NSAIDs)
GI effects
Elevated liver enzymes
Hyperurecemia
Increases glucose levels/insulin resistance

19
Q

What are C/I of Niacin?

A

Peptic ulcer
Hepatic disease (MAJOR)
Gout
Diabetes

20
Q

What are clinical uses of Niacin?

A

Hypercholesterolemia
Hypertriglyceridemia
Reduces Lp(a)

21
Q

What is lipoprotein profile of Niacin?

A

TG - decreased 35-50%
LDL - decreased 25%
HDL - increased 15-30%
Lp(a) - reduced 40%

22
Q

What is the mechanism of action of Ezetimibe?

A

It inhibits protein transporter Niemann Pick C10 like protein to cause decreased rate of cholesteryl ester incorporation into chylomicrons –> causes increased expression of hepatic LDL receptor

23
Q

What are the pharmacokinetics of Ezetimibe?

A

Oral administration
Metabolized to active metabolite
22 hour half life

24
Q

What are the adverse effects of Ezetimibe?

A

Normally well tolerated

S/E increase if combined with other drugs

25
What are the clinical uses of Ezetimibe?
Hypercholesterolemia | Combined with statins - unsure if helpful
26
What is the lipoprotein profile of Ezetimibe?
Modest decreases in TG, LDL and increases in HDL
27
What are the drugs of choice for Hypercholesterolemia?
Statins - HMG CoA Reductase inhibitors Bile acid resins - younger patient age range, add on to statins Ezetimibe - safe as mono therapy Niacin - patient compliance problems,
28
What are the drugs of choice for Hypertriglyceridemia?
Gemfibrozil/Fenofibrate Niacin Omega 3 FA
29
What are two examples of Fibric Acid?
Gemfibrozil and Fenofibrate
30
What is the mechanism of action of Gemfibrozil and Fenofibrate?
They are ligands for a nuclear transcription regulator called Peroxisome proliferator activated receptor that regulates gene expression and causes decreased TG, decreased inflammation, increased HDL synthesis and Increased Lipoprotein Lipase
31
What are the pharmacokinetics of Gemfibrozil and Fenofibrate?
Oral administration, plasma protein binding, half life varies, Fenofibrate is a prodrug
32
What are the adverse effects of Gemfibrozil and Fenofibrate?
Well tolerated GI symptoms Hematological Increased CK/renal failure when combined with statin
33
When are Fenofibrate and Gemfibrozil C/I?
Renal impairment (esp Fenofibrate)
34
What are the clinical uses of Fenofibrate and Gemfibrozil?
Patients with high TGs and low HDL (associated with metabolic syndrome and DM2)
35
What are the effects of Omega 3 FA?
Lipid lowering effects; inhibits lipogenesis, stimulates B oxidation, phospholipid synthesis and apolipoprotein B degradation
36
What is the clinical use for Omega 3 FA?
Adjunct to diet therapy in treatment of hypertriglyceridemia
37
What does the protein PCSK9 do?
It degrades the LDL receptor
38
What does the MTP protein do?
Transfers lipids between membrane vesicles; chaperone for biosynthesis of apoB containing TG rich lipoproteins (VLDL, chylomicrons)
39
What would be the clinical use for a MTP inhibitor?
Homozygous Familiar Hypercholesterolemia
40
What is the protein apo B 100?
It is an apolipoprotein essential for LDL-C and VLDL. IT helps LDL bind to it's receptor on hepatocytes
41
What would be the clinical use for an apoB inhibitor?
Homozygous Familial Hypercholesterolemia